Skip to content

A Randomized Trial of MBSR Versus Aerobic Exercise for Social Anxiety Disorder

Hooria Jazaieri, Philippe R. Goldin, Kelly Werner, Michal Ziv, James J. Gross

Journal of Clinical Psychology July 1, 2012 DOI: 10.1002/jclp.21863 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 56
Population Adults with social anxiety disorder; comparison groups included 48 healthy adults and 29 untreated adults with generalized social anxiety disorder
Intervention Aerobic exercise
Duration Pre-intervention to post-intervention and 3-month follow-up
Measures Liebowitz Social Anxiety Scale, Social Interaction Anxiety Scale, Beck Depression Inventory-II, Perceived Stress Scale, Rosenberg Self-Esteem Scale, Satisfaction with Life Scale, Self-Compassion Scale, UCLA-8 Loneliness Scale
Topics Anxiety Meditation
Key findings Both MBSR and aerobic exercise were associated with reductions in social anxiety and depression and increases in subjective well-being immediately post-intervention and at three months, and both intervention groups improved relative to an untreated social anxiety disorder group. The authors argue that nontraditional interventions such as MBSR and aerobic exercise merit further exploration as alternative or complementary treatments for social anxiety disorder.

Abstract

Objective: Effective treatments for social anxiety disorder (SAD) exist, but additional treatment options are needed for nonresponders as well as those who are either unable or unwilling to engage in traditional treatments. Mindfulness‐based stress reduction (MBSR) is one nontraditional treatment that has demonstrated efficacy in treating other mood and anxiety disorders, and preliminary data suggest its efficacy in SAD as well.

Method: Fifty‐six adults (52% female; 41% Caucasian; age mean [M] ± standard deviation [SD]: 32.8 ± 8.4) with SAD were randomized to MBSR or an active comparison condition, aerobic exercise (AE). At baseline and post‐intervention, participants completed measures of clinical symptoms (Liebowitz Social Anxiety Scale, Social Interaction Anxiety Scale, Beck Depression Inventory‐II, and Perceived Stress Scale) and subjective well‐being (Rosenberg Self‐Esteem Scale, Satisfaction with Life Scale, Self‐Compassion Scale, and UCLA‐8 Loneliness Scale). At 3 months post‐intervention, a subset of these measures was readministered. For clinical significance analyses, 48 healthy adults (52.1% female; 56.3% Caucasian; age [M ± SD]: 33.9 ± 9.8) were recruited. MBSR and AE participants were also compared with a separate untreated group of 29 adults (44.8% female; 48.3% Caucasian; age [M ± SD]: 32.3 ± 9.4) with generalized SAD who completed assessments over a comparable time period with no intervening treatment.

Results: A 2 (Group) x 2 (Time) repeated measures analyses of variance (ANOVAs) on measures of clinical symptoms and well‐being were conducted to examine pre‐intervention to post‐intervention and pre‐intervention to 3‐month follow‐up. Both MBSR and AE were associated with reductions in social anxiety and depression and increases in subjective well‐being, both immediately post‐intervention and at 3 months post‐intervention. When participants in the randomized controlled trial were compared with the untreated SAD group, participants in both interventions exhibited improvements on measures of clinical symptoms and well‐being.

Conclusion: Nontraditional interventions such as MBSR and AE merit further exploration as alternative or complementary treatments for SAD. © 2012 Wiley Periodicals, Inc. J. Clin. Psychol. 68:715‐731, 2012

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Cited by 39

and 34 more in the library

Cites 16

and 11 more in the library

Explore topics